Dyslipidaemia and inflammation are risks for subclinical atherosclerotic vascular disease among chronic kidney failure patients in South Africa
PLOS One · 10.11.2025 · 20 (11) · e0323882
DOI: 10.1371/journal.pone.0323882 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 10.11.2025. Verfasst von S O Oguntola und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa. Hauptthemen laut MEDLINE: Kidney Failure, Chronic, Inflammation, Atherosclerosis, Dyslipidemias. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Chronic kidney disease (CKD) is associated with generalized inflammation. The presence of CKD-related (non-traditional) cardiovascular disease (CVD) risk factors such as inflammation, oxidative stress and uraemic toxins worsen the CVD. A distinct form of lipoprotein alteration known as uraemic dyslipidaemia, characterized by normal low-density lipoprotein (LDL), reduced high density lipoprotein (HDL) and elevated triglyceride and lipoprotein (a) has been described in CKD. The combination of all these factors increase the cardiovascular risk in CKD patients. We evaluated the relationship of lipoprotein and inflammatory biomarkers to atherosclerotic vascular disease (AsVD) among stage 3 CKD, end stage kidney disease (ESKD) patients on continuous ambulatory peritoneal dialysis (CAPD) and haemodialysis (HD) and kidney transplant recipients (KTRs).
Methods
This was a cross-sectional study of 40 adult (18–65 years) non-diabetic stage 3 CKD patients, 40 CAPD and 40 HD patients, 41 KTRs and 41 age- and sex-matched healthy controls. Socio-demographic and cardiovascular risk factors were documented and serum samples were analysed for inflammatory and lipoprotein markers. Echocardiography was performed and carotid intima media thickness (CIMT) was measured in all participants.
Results
The overall prevalence of AsVD was 52.8% in the study population, with the highest burden of inflammation present in CAPD patients. Significantly increased levels of hsCRP, pentraxin-3, Lp(a) and Lp-PLA2 were seen in CAPD, compared to controls. Older age, male gender, reduced high-density lipoprotein (HDL-C) and elevated Lp(a) levels were independently associated with AsVD.
Conclusion
The burden of inflammation and lipoprotein abnormalities was greatest among end stage kidney disease (ESKD) patients and was the highest in CAPD patients. Lipoprotein(a) independently predicted AsVD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Department of Medicine, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa.
- Nephrology Unit, Department of Medicine, Faculty of Clinical Sciences, College of Medicine and Health Sciences, Afe Babalola University, Ado-Ekiti, Ekiti State, Nigeria.
- Department of Internal Medicine, Uniosun Teaching Hospital, Osogbo, Osun State, Nigeria.
- Department of Medicine, Obafemi Awolowo University, Ile-Ife, Nigeria.
- Department of Internal Medicine Laboratory, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa.
- Department of Chemical Pathology, University of the Witwatersrand, Johannesburg, South Africa.
ORCID-Profile: S O Oguntola, S Naicker
Zitieren
APA
Oguntola, S. O., Hassan, M. O., Duarte, R., Dickens, C., Dix-Peek, T., Snyman, T., Moodley, K., Olorunfemi, G., Vachiat, A., Manga, P., & Naicker, S. (2025). Dyslipidaemia and inflammation are risks for subclinical atherosclerotic vascular disease among chronic kidney failure patients in South Africa. PLOS One, 20(11), e0323882. https://doi.org/10.1371/journal.pone.0323882
Vancouver
Oguntola SO, Hassan MO, Duarte R, Dickens C, Dix-Peek T, Snyman T, et al. Dyslipidaemia and inflammation are risks for subclinical atherosclerotic vascular disease among chronic kidney failure patients in South Africa. PLOS One. 2025;20(11):e0323882. doi:10.1371/journal.pone.0323882
BibTeX
@article{Oguntola2025,
author = {Oguntola, S O and Hassan, M O and Duarte, R and Dickens, C and Dix-Peek, T and Snyman, T and Moodley, K and Olorunfemi, G and Vachiat, A and Manga, P and Naicker, S},
title = {Dyslipidaemia and inflammation are risks for subclinical atherosclerotic vascular disease among chronic kidney failure patients in South Africa},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {11},
pages = {e0323882},
doi = {10.1371/journal.pone.0323882}
}
EUVIMED